- Home
- TXMD vs REVG Comparison
TXMD vs REVG Comparison
Compare TXMD & REVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- REVG
- Stock Information
- Founded
- TXMD 2008
- REVG 2008
- Country
- TXMD United States
- REVG United States
- Employees
- TXMD N/A
- REVG N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- REVG Auto Manufacturing
- Sector
- TXMD Health Care
- REVG Consumer Discretionary
- Exchange
- TXMD Nasdaq
- REVG Nasdaq
- Market Cap
- TXMD 12.8M
- REVG 2.2B
- IPO Year
- TXMD N/A
- REVG 2017
- Fundamental
- Price
- TXMD $1.19
- REVG $49.69
- Analyst Decision
- TXMD
- REVG Hold
- Analyst Count
- TXMD 0
- REVG 4
- Target Price
- TXMD N/A
- REVG $41.25
- AVG Volume (30 Days)
- TXMD 44.6K
- REVG 658.5K
- Earning Date
- TXMD 08-11-2025
- REVG 06-04-2025
- Dividend Yield
- TXMD N/A
- REVG 0.48%
- EPS Growth
- TXMD N/A
- REVG N/A
- EPS
- TXMD N/A
- REVG 1.86
- Revenue
- TXMD $1,841,000.00
- REVG $2,331,500,000.00
- Revenue This Year
- TXMD $427.09
- REVG $3.60
- Revenue Next Year
- TXMD N/A
- REVG $6.89
- P/E Ratio
- TXMD N/A
- REVG $26.68
- Revenue Growth
- TXMD 53.55
- REVG N/A
- 52 Week Low
- TXMD $0.70
- REVG $21.54
- 52 Week High
- TXMD $2.44
- REVG $50.34
- Technical
- Relative Strength Index (RSI)
- TXMD 49.81
- REVG 77.07
- Support Level
- TXMD $0.98
- REVG $48.52
- Resistance Level
- TXMD $1.21
- REVG $50.34
- Average True Range (ATR)
- TXMD 0.09
- REVG 1.19
- MACD
- TXMD 0.01
- REVG 0.15
- Stochastic Oscillator
- TXMD 82.48
- REVG 91.01
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About REVG REV Group Inc.
REV Group Inc is a United States-based designer, manufacturer, and distributor of specialty vehicles and related aftermarket parts and services. During the first fiscal quarter of 2024, the Company formed the Specialty Vehicles Segment by combining the Fire & Emergency and Commercial segment businesses. Additionally, the Recreation segment was renamed Recreational Vehicles. As a result, the Company is now organized into two reportable segments. The company operates in the United States, Canada, and the rest of the world. Maximum of revenue is gained from Specialty Vehicles Segment.